Table of Contents

Pharmaceuticals, Volume 6, Issue 3 (March 2013), Pages 287-439

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Readerexternal link to open them.
Display options:
Select articles Export citation of selected articles as:
Select/unselect all
Displaying article 1-7

Research

Jump to: Review

p. 295-319
by , , , ,  and
Pharmaceuticals 2013, 6(3), 295-319; doi:10.3390/ph6030295
Received: 11 January 2013; in revised form: 9 February 2013 / Accepted: 1 March 2013 / Published: 14 March 2013
Show/Hide Abstract | Cited by 4 | PDF Full-text (1085 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue RNAi-Based Therapeutics)
p. 320-339
by , , , ,  and
Pharmaceuticals 2013, 6(3), 320-339; doi:10.3390/ph6030320
Received: 23 February 2013; in revised form: 6 March 2013 / Accepted: 7 March 2013 / Published: 18 March 2013
Show/Hide Abstract | Cited by 2 | PDF Full-text (1300 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Cell-penetrating Peptides)
abstract graphic
p. 393-406
by ,  and
Pharmaceuticals 2013, 6(3), 393-406; doi:10.3390/ph6030393
Received: 29 January 2013; Accepted: 13 March 2013 / Published: 21 March 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (697 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Biologics)

Review

Jump to: Research

p. 287-294
by  and
Pharmaceuticals 2013, 6(3), 287-294; doi:10.3390/ph6030287
Received: 31 December 2012; in revised form: 18 February 2013 / Accepted: 27 February 2013 / Published: 5 March 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (127 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue RNAi-Based Therapeutics)
p. 340-357
by
Pharmaceuticals 2013, 6(3), 340-357; doi:10.3390/ph6030340
Received: 16 February 2013; in revised form: 9 March 2013 / Accepted: 11 March 2013 / Published: 19 March 2013
Show/Hide Abstract | Cited by 2 | PDF Full-text (458 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Aptamer-Based Therapeutics)
p. 358-392
by  and
Pharmaceuticals 2013, 6(3), 358-392; doi:10.3390/ph6030358
Received: 28 January 2013; in revised form: 20 February 2013 / Accepted: 5 March 2013 / Published: 21 March 2013
Show/Hide Abstract | PDF Full-text (577 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Biologics)
p. 407-439
by
Pharmaceuticals 2013, 6(3), 407-439; doi:10.3390/ph6030407
Received: 11 December 2012; in revised form: 12 March 2013 / Accepted: 13 March 2013 / Published: 21 March 2013
Show/Hide Abstract | PDF Full-text (548 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Protein Kinase Inhibitors)
Select/unselect all
Displaying article 1-7
Select articles Export citation of selected articles as:
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert